Understanding insulin resistance
Walking is the most accessible, evidence-based exercise for people with diabetes. It requires no equipment, no gym membership, and no special fitness level. Yet its cardiovascular and metabolic benefits are profound: regular brisk walking reduces HbA1c, lowers blood pressure, improves cholesterol, aids weight management, and reduces the risk of major cardiovascular events by up to…
SGLT2 inhibitors represent one of the most transformative developments in diabetes medicine in the past decade. Originally approved as glucose-lowering agents, these medications have since demonstrated remarkable protective effects on the heart and kidneys — benefits so significant that they are now recommended for people with heart failure and chronic kidney disease even in the…
Exercise is one of the most powerful tools for managing diabetes and protecting cardiovascular health. Yet for many people with diabetes — particularly those on insulin or sulfonylureas — the fear of hypoglycaemia during or after exercise is a genuine barrier to physical activity. Understanding how different types of exercise affect blood glucose allows you…
GLP-1 receptor agonists were originally developed to lower blood sugar. What researchers discovered in subsequent cardiovascular outcome trials was something far more significant: these medications actively protect the heart, reduce the risk of stroke, and lower cardiovascular mortality — benefits that extend well beyond glucose control. The Landmark Cardiovascular Outcome Trials Trial Drug Key Finding…
GLP-1 receptor agonists produce impressive weight loss, but a significant proportion of that weight can come from muscle rather than fat. Understanding how to minimise muscle loss while on these medications is essential for long-term metabolic health and functional capacity. The Muscle Loss Problem Clinical trials show that approximately 25–40% of weight lost on GLP-1…
Metformin has been the cornerstone of Type 2 diabetes treatment for over 60 years. With newer, more glamorous medications capturing headlines, it is worth examining what metformin still does exceptionally well — and where its limitations lie. Why Metformin Has Remained First-Line The landmark UKPDS demonstrated that metformin reduces cardiovascular mortality in overweight people with…
Retatrutide: A New Horizon in Diabetes and Obesity Management The global prevalence of type 2 diabetes and obesity continues to rise, posing significant health challenges and underscoring the urgent need for innovative and effective treatment strategies. For many individuals, managing these interconnected conditions involves a complex interplay of lifestyle modifications and pharmacological interventions. While existing…
Weight Training for Men with Diabetes: A Comprehensive Guide For men navigating the complexities of diabetes, the fitness landscape can often appear as a bewildering array of prescriptions and proscriptions. Yet, among the various strategies available, weight training emerges as an exceptionally potent tool, capable not only of aiding blood sugar management but also of…
For individuals managing diabetes, understanding the nuances of post-workout nutrition is paramount for optimizing blood glucose control, enhancing recovery, and maximizing the benefits of physical activity. Exercise significantly impacts glucose metabolism, and strategic nutritional intake after physical exertion can prevent both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar), which are critical concerns for…
The integration and sustained engagement in physical activity are fundamental components in the management of diabetes, offering profound benefits not only for glycemic regulation but also for overall cardiovascular and metabolic health. Nonetheless, the presence of diabetic complications necessitates a nuanced approach to exercise prescription. Tailored recommendations, grounded in current clinical evidence, are essential to…
Urdu 
English